This message was sent to ##Email##
|
|
|
|
|
| |
White House
The White House convened a Summit earlier this summer that was focused on reducing the wait list for transplantation. During that meeting a number of organizations announced new initiatives that were innovative and collaborative and intended to address the organ shortage.
In follow-up from the Summit, the White House has publicly announced an opportunity for additional commitments focused on transplantation. We encourage everyone within the transplant community to support the efforts of the White House and consider submitting initiatives that can collectively demonstrate the great work the field is doing to address important issues.
ABIM
The American Board of Internal Medicine (ABIM) is continuing to engage physicians to build a new Maintenance of Certification (MOC) assessment pathway that adheres to the high standards of certification while meeting additional needs of the physician community and the patients they serve.
As part of this ongoing effort, ABIM distributed a survey to all ABIM Board Certified physicians, seeking their preferences and insights. The survey includes information about two alternative MOC assessment pathways developed with physician input and now under discussion: a 5-year pathway and a 2-year pathway.
The survey, which will remain open until Oct. 31, takes 10-15 minutes to complete. ABIM diplomates can access the survey by signing in to abim.org and clicking “Make your opinion count: Take survey about new MOC assessment.”
OPTN
There are 15 proposals currently out for public comment. Please take some time to review these proposals and share this information within your institutions. Feedback is critical to the policy development process. The AST's COPs are finalizing their review of proposals this week. Their responses will then go to the AST's Policy Committee for consideration to draft a unified AST response that will then go to the Board of Directors for approval before submission by the Oct. 14 deadline.
 |
|
• Write quality plans
• Document F-QAPI activities
• Review adverse events
• Assign tasks and to-do's
• Create meeting agendas and minutes
• Automate QA scorecards and reporting
• Analyze outcomes
|
|
AST
The nomination submission website for the 2017 AST Board of Directors is now open and accepting applications. AST recognizes the importance of electing strong leaders and encourages nominations from qualified AST members. Detailed information and the nomination criteria can be found here.
AST
Visit the AST Member Spotlight section of the website to find out what transplantation means to Dr. Helen Te and why she chose to work in this exciting field!
Interested in being featured in the AST Member Spotlight? Please contact rmassi@myAST.org for more information.
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
AST
Oct. 18, 2016 2 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/t3
AST
Oct. 26, 2016 1 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/optimizing-your-living-kidney-donor-program-1
Register today!
BeST16 Basic Science in Transplantation
The basic science community within our field is a tight-knit, dynamic group that benefits greatly from dedicated meeting opportunities to share knowledge and establish collaborations. As such, we hope you will join us at BeST16: Basic Science in Transplantation, a meeting jointly sponsored by the AST and ESOT.
HOUSING IS NOW OPEN
CEOT
The deadline to submit abstracts is Friday, November 18, 2016. To find out how to submit an abstract, please click here.
ATC
The American Transplant Congress is designed for physicians, surgeons, scientists, nurses, organ procurement personnel and pharmacists who are interested in the clinical and research aspects of solid organ and tissue transplantation. The meeting will provide the most current information in the field of transplant science. The deadline to submit abstracts is Friday, Dec. 2, 2016. For more information regarding abstract submission, please click here.
American Journal of Transplantation
The Banff Working Group on Liver Allograft Pathology reviewed and discussed literature evidence regarding antibody-mediated liver allograft rejection at the 11th (Paris, France, June 5–10, 2011), 12th (Comandatuba, Brazil, Aug. 19–23, 2013), and 13th (Vancouver, British Columbia, Canada, Oct. 5–10, 2015) meetings of the Banff Conference on Allograft Pathology.
READ MORE
American Journal of Transplantation
Selection criteria and benefit of liver transplantation for hepatic metastases from neuroendocrine tumors (NETs) remain uncertain. Eighty-eight consecutive patients with metastatic NETs eligible for liver transplantation according to Milan-NET criteria were offered transplant (n = 42) versus nontransplant options (n = 46) depending on list dynamics, patient disposition, and age. Tumor burden between groups did not differ.
READ MORE
American Journal of Transplantation
Death rates from drug overdoses have nearly doubled since 2003, with over 47 000 deaths in 2014. This is largely attributable to the opioid epidemic. If the unfortunate deaths of otherwise healthy people have yielded an increase in organ donors, then this might serve as perhaps the only comforting factor among this tragic and unnecessary loss of life.
READ MORE
American Journal of Transplantation
The indication for antimicrobial treatment of asymptomatic bacteriuria (AB) after kidney transplantation (KT) remains controversial. Between January 2011 and December 2013, 112 KT recipients that developed one episode or more of AB beyond the second month after transplantation were included in this open-label trial.
READ MORE
The American Journal of Transplantation
Intestinal transplantation (ITx) remains challenged by frequent/severe rejections and immunosuppression-related complications (infections/malignancies/drug toxicity). We developed the Leuven Immunomodulatory Protocol (LIP) in the lab and translated it to the clinics. LIP consists of experimentally proven maneuvers, destined to promote T-regulatory (Tregs)-dependent graft-protective mechanisms: donor-specific blood transfusion (DSBT); avoiding high-dose steroids/calcineurin-inhibitors; and minimizing reperfusion injury and endotoxin translocation.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
